An improvement in digoxin bioavailability. Studies with soft gelatin capsules containing a solution of digoxin. 1979

V Alvisi, and C Longhini, and B Bagni, and F Portaluppi, and M Ruina, and C Fersini

A study of relative bioavailability of two digoxin formulations was carried out on 28 healthy volunteer human subjects of both sexes. A commercial digoxin in tablet form was compared with a new commercial formulation which contains a solution of digoxin in soft gelatin capsules. The parameters investigated were: plasma levels, area under the plasma level-time curve, daily urinary excretion of digoxin and a series of polycardiographic measurements, all the parameters being evaluated in a steady-state condition (14 days of treatment). All the parameters investigated demonstrated better bioavailability in the capsules than in the tablets, the average improvement being 26.1%. The better bioavailability of digoxin capsules also resulted in more rapid and wider variations in the polycardiographic parameters.

UI MeSH Term Description Entries
D008297 Male Males
D002214 Capsules Hard or soft soluble containers used for the oral administration of medicine. Capsule,Microcapsule,Microcapsules
D004077 Digoxin A cardiotonic glycoside obtained mainly from Digitalis lanata; it consists of three sugars and the aglycone DIGOXIGENIN. Digoxin has positive inotropic and negative chronotropic activity. It is used to control ventricular rate in ATRIAL FIBRILLATION and in the management of congestive heart failure with atrial fibrillation. Its use in congestive heart failure and sinus rhythm is less certain. The margin between toxic and therapeutic doses is small. (From Martindale, The Extra Pharmacopoeia, 30th ed, p666) Digacin,Digitek,Digoregen,Digoxina Boehringer,Digoxine Nativelle,Dilanacin,Hemigoxine Nativelle,Lanacordin,Lanicor,Lanoxicaps,Lanoxin,Lanoxin-PG,Lenoxin,Mapluxin,Boehringer, Digoxina,Lanoxin PG,Nativelle, Digoxine,Nativelle, Hemigoxine
D004562 Electrocardiography Recording of the moment-to-moment electromotive forces of the HEART as projected onto various sites on the body's surface, delineated as a scalar function of time. The recording is monitored by a tracing on slow moving chart paper or by observing it on a cardioscope, which is a CATHODE RAY TUBE DISPLAY. 12-Lead ECG,12-Lead EKG,12-Lead Electrocardiography,Cardiography,ECG,EKG,Electrocardiogram,Electrocardiograph,12 Lead ECG,12 Lead EKG,12 Lead Electrocardiography,12-Lead ECGs,12-Lead EKGs,12-Lead Electrocardiographies,Cardiographies,ECG, 12-Lead,EKG, 12-Lead,Electrocardiograms,Electrocardiographies, 12-Lead,Electrocardiographs,Electrocardiography, 12-Lead
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities
D012996 Solutions The homogeneous mixtures formed by the mixing of a solid, liquid, or gaseous substance (solute) with a liquid (the solvent), from which the dissolved substances can be recovered by physical processes. (From Grant & Hackh's Chemical Dictionary, 5th ed) Solution
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

V Alvisi, and C Longhini, and B Bagni, and F Portaluppi, and M Ruina, and C Fersini
January 1976, Bollettino della Societa italiana di cardiologia,
V Alvisi, and C Longhini, and B Bagni, and F Portaluppi, and M Ruina, and C Fersini
December 1975, Clinical pharmacology and therapeutics,
V Alvisi, and C Longhini, and B Bagni, and F Portaluppi, and M Ruina, and C Fersini
January 1979, British journal of clinical pharmacology,
V Alvisi, and C Longhini, and B Bagni, and F Portaluppi, and M Ruina, and C Fersini
March 1977, Clinical pharmacology and therapeutics,
V Alvisi, and C Longhini, and B Bagni, and F Portaluppi, and M Ruina, and C Fersini
February 1978, Bollettino chimico farmaceutico,
V Alvisi, and C Longhini, and B Bagni, and F Portaluppi, and M Ruina, and C Fersini
October 1974, Bollettino della Societa italiana di biologia sperimentale,
V Alvisi, and C Longhini, and B Bagni, and F Portaluppi, and M Ruina, and C Fersini
March 1976, Journal of pharmaceutical sciences,
V Alvisi, and C Longhini, and B Bagni, and F Portaluppi, and M Ruina, and C Fersini
July 1978, International journal of clinical pharmacology and biopharmacy,
V Alvisi, and C Longhini, and B Bagni, and F Portaluppi, and M Ruina, and C Fersini
September 1977, The Journal of pharmacy and pharmacology,
V Alvisi, and C Longhini, and B Bagni, and F Portaluppi, and M Ruina, and C Fersini
December 1977, European journal of clinical pharmacology,
Copied contents to your clipboard!